Rolfo, CHRISTIAN DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 3.926
EU - Europa 697
AS - Asia 422
SA - Sud America 5
AF - Africa 4
OC - Oceania 2
Totale 5.056
Nazione #
US - Stati Uniti d'America 3.922
IT - Italia 254
CN - Cina 209
SG - Singapore 154
FI - Finlandia 75
DE - Germania 69
GB - Regno Unito 65
IE - Irlanda 63
SE - Svezia 35
RU - Federazione Russa 34
RO - Romania 16
ES - Italia 15
BE - Belgio 14
IN - India 10
KR - Corea 10
TR - Turchia 9
FR - Francia 8
UA - Ucraina 7
CH - Svizzera 6
IR - Iran 6
NL - Olanda 6
GR - Grecia 5
HK - Hong Kong 5
CI - Costa d'Avorio 4
JP - Giappone 4
AL - Albania 3
CA - Canada 3
CL - Cile 3
CZ - Repubblica Ceca 3
LT - Lituania 3
PL - Polonia 3
RS - Serbia 3
UZ - Uzbekistan 3
AT - Austria 2
BR - Brasile 2
HR - Croazia 2
LB - Libano 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
EE - Estonia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
MC - Monaco 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 5.056
Città #
Fairfield 723
Ashburn 364
Woodbridge 355
Seattle 308
Chandler 307
Houston 303
Cambridge 275
Wilmington 258
Ann Arbor 167
Singapore 130
Palermo 69
Medford 67
Dublin 62
Altamura 51
Princeton 42
Nanjing 41
Des Moines 39
Lawrence 38
Twinsburg 32
New York 31
Santa Clara 30
San Diego 27
Beijing 25
Dearborn 25
Boardman 19
Nanchang 19
London 18
Ludwigshafen am Rhein 17
Shenyang 17
Redwood City 16
Brussels 14
Phoenix 14
Changsha 13
Helsinki 12
Hebei 11
Jinan 11
Tianjin 11
Tulsa 11
Los Angeles 10
San Paolo di Civitate 10
Chicago 9
Jiaxing 9
Milazzo 9
Rome 9
Izmir 8
Seongnam 8
Ningbo 7
Bremen 6
Kitzingen 6
Madrid 6
Zhengzhou 6
Forest City 5
Hangzhou 5
Milan 5
Saint Petersburg 5
Abidjan 4
Barcelona 4
Guangzhou 4
Norwalk 4
Orange 4
Parma 4
Shanghai 4
St Petersburg 4
Amsterdam 3
Detroit 3
Edinburgh 3
Pune 3
Renton 3
Tappahannock 3
Tirana 3
Tokyo 3
Washington 3
Absecon 2
Athens 2
Bangkok 2
Berlin 2
Catania 2
Central District 2
Chiswick 2
Columbus 2
Dolovo 2
Durham 2
Falls Church 2
Frankfurt am Main 2
Genoa 2
Hong Kong 2
Hounslow 2
Islington 2
Kilburn 2
Kumar 2
Kunming 2
Messina 2
Moscow 2
Naples 2
Novokuznetsk 2
Prescot 2
Rootstown 2
San Francisco 2
Sector 6 2
Stuttgart 2
Totale 4.210
Nome #
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 192
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 188
Exosomes in semen: Opportunities as a new tool in prostate cancer diagnosis 181
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 172
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 169
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21 165
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 164
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 162
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 154
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 152
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 151
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward 150
Multisciplinary management of patients with liver metastasis from colorectal cancer 144
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 142
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 139
Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition 136
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 135
Cancer and the microbiome: Potential applications as new tumor biomarker 135
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 132
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 129
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… 126
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment 122
Exosomes as diagnostic and predictive biomarkers in lung cancer 121
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 117
Targeting angiogenesis in biliary tract cancers: An open option 116
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy 114
Improving extracellular vesicles visualization: From static to motion 111
Upfront radiation versus EGFR-TKI: Which is the best approach for EGFR-mutated NSCLC patients with brain metastasis? 110
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 110
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 109
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 108
Effects of exosomes released by NSCLC cells on osteoclasts differentiation. 107
BRAF mutations in non-small cell lung cancer: Has finally Janus opened the door? 107
Ramucirumab and its use in gastric cancer treatment 106
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 101
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 78
Role of NSCLC exosomes in osteoclast differentiation 77
VIPoma and PPoma 77
Curcumin induces selective packaging of miR-21 in exosomes released by Chronic Myelogenous Leukemia cells 68
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 64
Indications for locoregional tumor therapies: CRC liver metastases 58
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 51
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 44
null 16
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors 11
Liquid biopsy: a right tool in a right context? 11
Totale 5.332
Categoria #
all - tutte 20.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020991 0 0 0 0 189 186 150 127 142 98 66 33
2020/2021756 62 27 50 56 65 69 52 66 53 132 69 55
2021/2022574 31 107 30 20 19 27 20 45 61 81 45 88
2022/2023811 73 168 36 112 83 122 29 61 66 3 39 19
2023/2024363 14 48 26 26 19 56 63 23 18 11 3 56
2024/2025260 11 69 81 71 28 0 0 0 0 0 0 0
Totale 5.332